Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix A Agendas of Public Meetings Held by the Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides (Seventh Biennial Update) FIRST PUBLIC MEETING Thursday, March 27, 2008 National Academies of Science, Room 150 2101 Constitution Avenue, NW Washington, DC 20418 Presentations â¢ Welcome; Goals and Conduct of the Public Meeting; Introduction Richard Fenske, PhD, Committee Chair â¢ Charge to the Committee Mark Brown, PhD, US Department of Veterans Affairs â¢ IOM Veterans and Agent Orange Reports: A Brief History David Butler, PhD, Institute of Medicine â¢ Report of the Committee on Making Best Use of the Agent Orange Reconstruction Model Lois Joellenbeck, PhD, Institute of Medicine â¢ Possibility of Epigenetic Mechanisms for Dioxin, Particularly for Transgenerational Effects Barbara R. Migeon, MD, Institute of Genetic Medicine, Johns Hopkins Hospital Michael K. Skinner, PhD, Washington State University (by phone) 663
664 VETERANS AND AGENT ORANGE: UPDATE 2008 â¢ Activities Involving the Vietnamese Population Vaughan C. Turekian, PhD, Chief International Officer, AAAS and representative to US-Vietnam Dialogue Group on Agent Orange/Dioxin SECOND PUBLIC MEETING Thursday, June 19, 2008 Hyatt Regency San Antonio 123 Losoya Street San Antonio, TX 78205 Presentations â¢ Welcome; Goals and Conduct of the Public Meeting; Introduction Richard Fenske, PhD, Committee Chair â¢ Toxicity of Organic Arsenic Samuel Cohen, MD, PhD, University of Nebraska Medical Center Placido Salazar, State Veteransâ Affairs Officer, American GI Forum Alberto Zambrano, Colonel USAF (retired) â¢ Possible Association Between Parkinsonâs Disease and the Herbicides Sprayed in Vietnam Steve Fiscus, President, US Military Veterans with Parkinsonâs (USMVP) Alan Oates, Director Special Projects, USMVP Lorenzo Gonzalez, VP, USMVP Christopher Reid, MD, PhD, Charles Drew University of Medicine and Science â¢ Genetic Implications Isaac D. Brown, III, PhD, AMVETS & DAV â¢ Delayed Onset of Symptoms Don Wilson, Military Order of the Purple Heart â¢ Conditions Not Covered Alexander Hill, Vietnam Veterans of America â¢ Blue Water Navy Issue John Wells, Esq., Commander USN (retired) â¢ Air Force Health Study Joel E. Michalek, PhD, University of Texas Health Center at San Antonio â¢ Written Statements Received Jon Anderson, Concerning PD and use of dieldrin in Vietnam
APPENDIX A 665 Ronald Denbow, Concerning possible role of compromised immune system increasing sensitivity to dioxin toxicity Jerry Dittmer, Concerning renal cell carcinoma Michael Eckstein, Concerning nerve disorders and birth defects Michael J. Harris, Concerning child with fascioscapular humeral dystrophy THIRD PUBLIC MEETING December 8, 2008 Beckman Center 100 Academy Rd. Irvine, CA Presentations â¢ Welcome; Goals and Conduct of the Public Meeting; Introduction Richard Fenske, Committee Chair â¢ Effects of Dioxin on Mitochondria and What the Implications Might Be for Dioxinâs Carcinogenic Potential and for Inducing Other Chronic or Transgenerational Adverse Health Outcomes Doug Wallace, University of California, Irvine